Sign In
Buy ALNY
$297.69
+5.53 (+1.89%)
At Close: Jun 09, 2026
Alnylam Reports New 12-Month Interim Data From the ENVISION Phase 3 Study of Givosiran in Acute Hepatic Porphyria
12:00am, Tuesday, 30'th Jun 2020
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced the presentation of new data from the open-label
New Pharma ETF Focuses on Testing and Treatment for Infectious Diseases--but Not Covid-19
08:51pm, Sunday, 28'th Jun 2020
GERM offers investors exposure to established providers and ‘unsung heroes’ of biotech and life sciences Continue reading...
1832 Asset Management L.P. Purchases Shares of 20,900 Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)
10:28am, Sunday, 28'th Jun 2020
1832 Asset Management L.P. purchased a new stake in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) during the 1st quarter, according to the company in its most recent disclosure with the Securities and E
Coronavirus update: U.S. sets another record for new cases and some states scramble to revisit their reopening plans
03:55pm, Saturday, 27'th Jun 2020
The number of new confirmed cases of the coronavirus illness COVID-19 set another fresh record in the U.S. on Friday, according to data aggregated by Johns...
Coronavirus update: U.S. sets record for new cases in a single day, as Texas becomes first state to reimpose restrictions
06:32pm, Friday, 26'th Jun 2020
The number of new confirmed cases of the coronavirus illness COVID-19 set a fresh record in the U.S. on Thursday of almost 40,000, according to data...
Could Gilead Stock Get A Boost From Inhaled Remdesivir?
12:00am, Friday, 26'th Jun 2020
Gilead has indicated that it would be starting clinical trials for an inhaled version of Remdesivir shortly. While the wide-spectrum anti-viral drug is currently given intravenously for severe cases o
Why Dynavax, Novavax, and Vir Biotechnology Stocks Jumped Today | The Motley Fool
07:45pm, Wednesday, 24'th Jun 2020
Higher numbers of COVID-19 cases helped these biotechs, which are working on treatments and vaccines for the disease.
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs June 23)
ACADIA Pharmaceuticals Inc...
The Daily Biotech Pulse: Sanofi Expedites COVID-19 Vaccine Timeline, Apyx Cleared For Market Expansion, Miragen's Positive Readout
12:00am, Tuesday, 23'rd Jun 2020
The following is a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs June 22)
ADC Therapeutics SA (...
Is Alnylam a Good Biotech Stock to Buy Now? | The Motley Fool
12:23pm, Sunday, 21'st Jun 2020
This biotech could earn its third new drug approval in as many years.
Mackenzie Financial Corp Increases Position in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)
07:22am, Sunday, 21'st Jun 2020
Mackenzie Financial Corp increased its stake in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) by 31.1% in the 1st quarter, according to its most recent disclosure with the SEC. The institutional investo
